Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on June 12, 2025
Peripheral Vascular Intervention Market projected to surpass US$18.198 billion by 2030 at a CAGR of 5.74%
EIN Presswire
·
June 12, 2025
The peripheral vascular intervention market is anticipated to grow at a CAGR of 5.74% from US$13.765 billion in 2025 to US$18.198 billion by 2030. NEW YORK, NY, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- According to a new study published by …
Global Embedded Finance Market Set For 21.8% Growth, Reaching $208.89 Billion By 2029
EIN Presswire
·
June 12, 2025
The Business Research Company's Embedded Finance Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 12, 2025 /EINPresswire.com/ -- The embedded finance market is experiencing …
Embodied Artificial Intelligence AI Market Report 2025: Size, Trends, And Growth Insights For Global Expansion
EIN Presswire
·
June 12, 2025
The Business Research Company's Embodied Artificial Intelligence AI Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 12, 2025 /EINPresswire.com/ -- The embodied artificial …
IPV Vaccines Market Set to Expand at CAGR of 8.7% Through 2032 | Sanofi Pasteur, GlaxoSmithKline plc
EIN Presswire
·
June 12, 2025
IPV Vaccines Market Research Report Information By Vaccine Brand, By Distribution Channel, And By Region MI, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- IPV Vaccines Insights The global IPV vaccines market is estimated to be valued at USD 199. …
Cholangiocarcinoma Market Booming Worldwide, Estimated to Reach USD 2,334.4 Mn by 2032 | Incyte Corporation
EIN Presswire
·
June 12, 2025
Cholangiocarcinoma Market Research Report Information By Cancer Type, By Therapy Type, By Route of Administration, By Distribution Channel, And By Region KS, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- Cholangiocarcinoma Market is estimated to be …
Somatropin Market Projected to Witness Massive Growth, Surpassing USD 7.25 Billion by 2032 | Pfizer Inc., Novo Nordisk
EIN Presswire
·
June 12, 2025
Somatropin Market Research Report Information By Dosage Form, By Application, By Distribution Channel, and By Region GA, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- Somatropin Insights Somatropin Market is estimated to be valued at USD 4.43 Bn …
Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025
GlobeNewswire
·
June 12, 2025
Seven months after the completion of dosing: 41% of patients (150 mg Q4W) continue to experience complete response (UAS7=0) 48% of patients (150 mg Q4W) report that CSU no longer impacts their quality of life (DLQI=0/1) KIT related tolerability events …
Clamps Market Detailed in New Research Report, Expected to Cross USD 270.42 Million by 2032 | B. Braun Melsungen AG
EIN Presswire
·
June 12, 2025
Clamps Market Research Report Information By Product Type, By End User, And By Region FL, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- Clamps Insights The Clamps Market is expected to expand its roots at a CAGR of 2.8% during 2022 to 2032. The …
Zopiclone Market Set to Witness Strong Growth, Reaching USD 2.5 Billion by 2033 | Sun Pharmaceutical Industries Ltd.
EIN Presswire
·
June 12, 2025
Zopiclone Market Research Report Information By Medicine Type, By Distribution Channel, And By Region CA, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- Zopiclone Insights The Zopiclone Market was worth USD 1.5 billion in 2024 and is projected to …
Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders
GlobeNewswire
·
June 12, 2025
SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today announced that the company’s 2025 annual meeting of …
Hapbee Is Upgrading U.S. Listing to OTCID to Expand Investor Access and Increase Market Visibility
GlobeNewswire
·
June 12, 2025
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB | OTC: HAPBF) (“Hapbee” or the “Company”), a leading wearable wellness technology company, is pleased to announce that its U.S. listing has been upgraded …
Banner Health’s clinical leader driving care innovation
GlobeNewswire
·
June 12, 2025
PHOENIX, June 12, 2025 (GLOBE NEWSWIRE) -- Marjorie Bessel, MD, chief clinical officer at Banner Health, has been recognized as one of Modern Healthcare’s 50 Most Influential Clinical Executives for 2025. It is the third time in five years she has won this …
DBV Technologies participera au prochain congrès EAACI 2025
GlobeNewswire
·
June 12, 2025
Châtillon, France, le 12 juin (22:30 CEST) 2025 DBV Technologies participera au prochain congrès EAACI 2025 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market: DBVT ; CUSIP : 23306J309), une société biopharmaceutique en phase …
DBV Technologies to Participate in Upcoming EAACI Congress 2025
GlobeNewswire
·
June 12, 2025
Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today …
FibroGen Announces 1-for-25 Reverse Stock Split
GlobeNewswire
·
June 12, 2025
SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock ("Reverse Stock Split"), effective at 5:00 p.m. Eastern Time on …
Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL
GlobeNewswire
·
June 12, 2025
Data reported from the ongoing ATALANTA-1 Phase 1/2 study in a heavily pretreated relapsed refractory non-Hodgkin’s Lymphoma (R/R NHL) patient population demonstrate low rates of high-grade toxicities Of the 64 patients enrolled, 61 received treatment, …
Galapagos zal nieuwe ATALANTA-1 CAR-T data presenteren op EHA 2025, met lage toxiciteit en snelle, gedecentraliseerde toediening van vers, early-memory-verrijkt GLPG5101 bij R/R NHL
GlobeNewswire
·
June 12, 2025
Gegevens uit de lopende ATALANTA-1 fase 1/2-studie bij een zwaar voorbehandelde patiëntengroep met recidief/refractair non-Hodgkinlymfoom (R/R NHL) tonen lage percentages van hooggradige toxiciteiten aan Van de 64 ingeschreven patiënten werden er 61 …
Starton Therapeutics Announces Phase 2a Clinical Trial for Continuous Low-Dose Lenalidomide (STAR-LLD) in Multiple Myeloma Open for Enrollment
GlobeNewswire
·
June 12, 2025
Gabrail Cancer …
Centurion Service Group to auction all assets following the closure of Rockledge Hospital in Rockledge, FL
GlobeNewswire
·
June 12, 2025
Franklin Park, Illinois, June 12, 2025 (GLOBE NEWSWIRE) -- Centurion Service Group, an industry-leading medical equipment life-cycle company, has been selected to auction all medical and non-medical assets of Rockledge Hospital in Rockledge, FL. All …
Private Donors Give $350,000 To Precision Medicine Study for Colorectal Cancer Patients
GlobeNewswire
·
June 12, 2025
Springfield, Mo., June 12, 2025 (GLOBE NEWSWIRE) -- Philanthropic support from private donors is what’s helping fund a new study focused on advancing precision medicine for metastatic colorectal cancer patients. The Ron and Martha Doornink Foundation is …